adenosine diphosphate has been researched along with hmr 1098 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Davies, NW; Hudman, D; Norman, RI; Rainbow, RD; Standen, NB | 1 |
Akrouh, A; Kurata, HT; Lawton, JS; Nichols, CG; Remedi, MS; Zhang, HX | 1 |
2 other study(ies) available for adenosine diphosphate and hmr 1098
Article | Year |
---|---|
Reduced effectiveness of HMR 1098 in blocking cardiac sarcolemmal K(ATP) channels during metabolic stress.
Topics: Action Potentials; Adenosine Diphosphate; Animals; ATP-Binding Cassette Transporters; Benzamides; Guanidines; Iodoacetates; Male; Myocytes, Cardiac; Patch-Clamp Techniques; Pinacidil; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Inwardly Rectifying; Pyridines; Rats; Rats, Wistar; Receptors, Drug; Sarcolemma; Sodium Cyanide; Sulfonylurea Compounds; Sulfonylurea Receptors | 2005 |
HMR 1098 is not an SUR isotype specific inhibitor of heterologous or sarcolemmal K ATP channels.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; ATP-Binding Cassette Transporters; Benzamides; Blood Glucose; Diazoxide; Insulin; Islets of Langerhans; KATP Channels; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Pinacidil; Potassium Channels, Inwardly Rectifying; Receptors, Drug; Sarcolemma; Substrate Specificity; Sulfonylurea Receptors | 2011 |